VEGFA and liver cancer: The mice that received DEN injections demonstrated significant elevations in serological markers of liver cancer, angiogenesis, and proinflammatory cytokines, including AFP, DCP, VEGF, and TNF-α (All P < 0.001), compared to the negative control group.